These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8569189)

  • 21. [Study on thrombomodulin and plasminogen activator inhibitor type-1 in patients of pregnancy induced hypertension].
    Ma S; Bai C; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Dec; 34(12):712-4. PubMed ID: 11479955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental morphology and clinical correlations in pregnancies complicated by hypertension.
    Bartl W; Müller-Tyl E
    Biol Res Pregnancy Perinatol; 1985; 6(4):173-6. PubMed ID: 3904846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history.
    Tarim E; Bal N; Kilicdag E; Kayaselcuk F; Bağiş T; Kuscu E
    Arch Gynecol Obstet; 2006 Jul; 274(4):209-14. PubMed ID: 16649040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A deficiency of placental IL-10 in preeclampsia.
    Hennessy A; Pilmore HL; Simmons LA; Painter DM
    J Immunol; 1999 Sep; 163(6):3491-5. PubMed ID: 10477622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemostatic changes in pregnancy.
    Brenner B
    Thromb Res; 2004; 114(5-6):409-14. PubMed ID: 15507271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between maternal plasma thrombomodulin and infant birth weight in hypertensive disorders of pregnancy.
    Varol FG; Ozgen L; Sayin NC; Demir M
    Clin Appl Thromb Hemost; 2009; 15(2):166-70. PubMed ID: 19022800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of relative variables about prethrombosis state and its clinical significance in patients with pregnancy induced hypertension].
    Liu BY; Zhong M; Yu YH; Zheng L; Wang Q; Guo WL
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):85-8. PubMed ID: 12783694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE).
    Bosco C; Parra M; Barja P; Rodrigo R; Fernández V; Suarez M; Muñoz H
    Histol Histopathol; 2005 Oct; 20(4):1045-55. PubMed ID: 16136486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The vitronectin anchors on placenta tissue of hypertensive pregnancy].
    Chen XQ; Zhang GS
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):463-6. PubMed ID: 12212119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic parameters in patients with primitive venous hypertension.
    Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
    Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta.
    Chinni E; Colaizzo D; Margaglione M; Rubini C; D'Ambrosio RL; Giuliani F; Di Vagno G; Grandone E
    Thromb Res; 2008; 122(3):376-82. PubMed ID: 18342915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic abnormalities in patients with severe preeclampsia.
    Heilmann L; Rath W; Pollow K
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of the hemostasis parameters in the development of preeclampsia.
    Ho CH; Yang ZL
    Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies.
    Floridon C; Nielsen O; Hølund B; Sweep F; Sunde L; Thomsen SG; Teisner B
    Placenta; 2000 Nov; 21(8):754-62. PubMed ID: 11095924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia.
    Atamer Y; Koçyigit Y; Yokus B; Atamer A; Erden AC
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):60-6. PubMed ID: 15734086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.
    Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y
    J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White coat hypertension and haemostatic/fibrinolytic balance disorders.
    Makris T; Stavroulakis G; Papadopoulos D; Paizis I; Krespi P; Tsoukala C; Hatzizacharias A; Votteas V
    Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.
    Ota S; Miyamura H; Nishizawa H; Inagaki H; Inagaki A; Inuzuka H; Suzuki M; Miyazaki J; Sekiya T; Udagawa Y; Kurahashi H
    Placenta; 2013 Dec; 34(12):1202-10. PubMed ID: 24140079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.